Researchers sought to determine the humoral immune response to the COVID-19 vaccine in patients with cancer after a third or fourth dose of the vaccine or breakthrough infection.
Survivors with four to seven types of discrimination events had large, clinically meaningful increase in deficits.
Nirogacestat is an oral, selective, small molecule gamma-secretase inhibitor that works by blocking proteolytic activation of Notch receptors.
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
A study evaluated prescribing practices for management of immune-mediated adverse events with immune checkpoint inhibitor therapy at a hospital system.
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
In the US, AYAs with cancer face high economic and human costs throughout their lifetime.
Screening for breast, cervical, and prostate cancer did not return to pre-pandemic levels in 2021 in the United States, a study suggests.
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
